Value Forum
MNV
Market News Video
MNV MNV Model Portfolios
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Reminder - C.R. Bard, Inc. (BCR) Goes Ex-Dividend Soon
Tuesday, October 16, 10:28 AM ET, by Market News Video Staff

On 10/18/12, C.R. Bard, Inc. ...

BCR Crosses Below Key Moving Average Level
Monday, October 22, 10:57 AM ET, by Market News Video Staff

In trading on Monday, shares of C.R. Bard, Inc. ...

C.R. Bard, Inc. Enters Oversold Territory (BCR)
Wednesday, October 24, 12:20 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Edwards Lifesciences Corp (EW) Shares Cross Above 200 DMA
Friday, November 2, 12:55 PM ET, by Market News Video Staff

In trading on Friday, shares of Edwards Lifesciences Corp (EW) crossed above their 200 day ...

BCR Crosses Above Key Moving Average Level
Monday, December 3, 11:48 AM ET, by Market News Video Staff

In trading on Monday, shares of C.R. Bard, Inc. ...

  More articles:  1 2 3 4 5 6 7 next »

DSCI Selling 9.5% Below CEO's Recent Buy Price

By Market News Video Staff, Wednesday, November 23, 2:54 PM ET
Now Playing: One Reason For Insiders to Buy


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 20, Derma Sciences Inc.'s CEO, Edward J. Quilty, invested $40,606.50 into 5,000 shares of DSCI, for a cost per share of $8.12. Bargain hunters tend to pay particular attention to insider buys like this one, because presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money.

In trading on Wednesday, bargain hunters could buy shares of Derma Sciences Inc. (NASDAQ:DSCI) and achieve a cost basis 9.5% cheaper than Quilty, with shares changing hands as low as $7.35 per share. Derma Sciences Inc. shares are currently trading down about 0.8% on the day. The chart below shows the one year performance of DSCI shares, versus its 200 day moving average:

Derma Sciences Inc. Chart

Looking at the chart above, DSCI's low point in its 52 week range is $4.50 per share, with $12.72 as the 52 week high point — that compares with a last trade of $7.51. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months:

Purchased Insider Title Shares Price/Share Value
09/06/2011 Bruce F. Wesson Director 10,000 $8.08 $80,764.00
09/20/2011 William C. Martin 14,168 $8.01 $113,475.19
09/20/2011 Edward J. Quilty President & CEO 5,000 $8.12 $40,606.50
09/26/2011 William C. Martin 29,823 $7.75 $231,202.44
09/29/2011 William C. Martin 7,571 $7.81 $59,144.56
10/04/2011 William C. Martin 15,000 $7.60 $114,000.00
10/18/2011 William C. Martin 93,544 $8.10 $757,528.05

DSCI operates in the Medical Instruments & Supplies sector, among companies like C.R. Bard, Inc. (NYSE:BCR) which is off about 1.2% today, and Edwards Lifesciences Corp (NYSE:EW) trading lower by about 0.3%. Below is a three month price history chart comparing the stock performance of DSCI, versus BCR and EW.

DSCI,BCR,EW Relative Performance Chart


Free Trial: ''ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO''

The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors — anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors, commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow the performance trail wherever it leads us.

Find the right mix of model portfolios today at PortfolioChannel.com


Top Six Most Viewed Stories This Week @ Market News Video:
Daily Wrap:  May 10, 2013Daily Wrap: May 10, 2013
Channel: Large Cap Stocks
Related symbols: MT,PCLN,GPS
Daily Dividend Report:  CRI, WM, CHRW, NVDA, CBIDaily Dividend Report: CRI, WM, CHRW, NVDA, CBI
Channel: Daily Dividend Report
Related symbols: CRI,WM,CHRW,NVDA,CBI
Daily Dividend Report:  MAR, LEG, ORI, OFC, RNDYDaily Dividend Report: MAR, LEG, ORI, OFC, RNDY
Channel: Daily Dividend Report
Related symbols: MAR,LEG,ORI,OFC,RNDY
Analyst Moves:  RIG, APC, BSXAnalyst Moves: RIG, APC, BSX
Channel: Upgrades/Downgrades
Related symbols: RIG,APC,BSX,CS,JEF,WFC
Analyst Moves:  DISH, MDR, PCLNAnalyst Moves: DISH, MDR, PCLN
Channel: Upgrades/Downgrades
Related symbols: DISH,MDR,PCLN,WFC
Daily Wrap:  May 9, 2013Daily Wrap: May 9, 2013
Channel: Large Cap Stocks
Related symbols: DISH,ZUMZ,ROST

This Article's Word Cloud:   DSCI   Derma   Director   Edward   Investment   Martin   NYSE   Quilty   Sciences   Value   William   about   above   allows   asset   below   buying   cash   chart   classes   completely   cost   currently   designed   hunters   insider   last   like   only   open   performance   point   portfolio   reason   recorded   share   shares   short   showing   stock   table   that   their   there   this   trading   versus   week   which   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use & Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  Econonomic News  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Market Definitions
MNV

DSCI Selling 9.5% Below CEO's Recent Buy Price | Market News Video | Copyright © 2008 - 2013, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.